Resources

Results per page

Selected Filters:

Point-of-Care Clear Filters

Product Brochures

Explore the services BBI Solutions has to offer

20 Feb 2023

Application Notes

Point-of-care monitoring for drugs of abuse

8 Feb 2023

Scientific Posters

Oncology research: Monitoring disease from diagnosis to remission

31 Jan 2023

Application Notes

The importance of human leukocyte antigen for the development of cell therapies

12 Jan 2023

Product Brochures

IBDoc® Calprotectin Home Test: A Step Forward towards Patient Empowerment

3 Jan 2023

White Papers

Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study

30 Nov 2022

Product Brochures

Complete solutions for lateral flow assay development

10 Nov 2022

Product Brochures

SARS-CoV-2 antibodies and antigens from Merck

10 Nov 2022

Product Brochures

News on diagnostics: Assay development and manufacture within the IVD market

10 Nov 2022

Application Notes

Microsphere coupling: Two-step EDC/Sulfo NHS covalent coupling procedure for Estapor carboxyl-modified dyed microspheres

10 Nov 2022

Product Brochures

Larger spheres equate to higher sensitivity: New Estapor IT 250 microspheres for LTIA

10 Nov 2022

Application Notes

Comparison of Estapor XC and Europium fluorescent microspheres in a quantitative lateral flow assay

10 Nov 2022

Product Brochures

Lateral flow assay development services

10 Nov 2022

Application Notes

Webinars to earn CE credits as a medical technologist

9 Nov 2022

Application Notes

N Latex FLC kappa and lambda assays

4 Nov 2022

Application Notes

Implementation of N latex free light chain kappa and lambda assays into routine practice

4 Nov 2022

Application Notes

Add consistency to monoclonal gammopathy testing: N latex FLC kappa and lambda assays

4 Nov 2022

White Papers

N latex FLC ratio for definition of ultra-high-risk smoldering multiple myeloma (SMM) - validation of the FLC rule 100

4 Nov 2022

Application Notes

The role of rapid diagnostics in tackling antimicrobial resistance

13 Oct 2022

Application Notes

Evaluation of the accuracy of LumiraDx INR Test in patients taking Phenprocoumon as VKA Therapy

13 Oct 2022

Application Notes

Performance evaluation of a rapid multiplex point-of-care microfluidic immunofluorescence assay for the detection of SARS-CoV-2 Antigen and Flu A/B

13 Oct 2022

Scientific Posters

Performance evaluation of a microfluidic point of care test for C-Reactive Protein

13 Oct 2022

Scientific Posters

Correlation of the LumiraDx SARS-CoV-2 antibody Test to other SARS-CoV-2 antibody tests and to viral neutralization

13 Oct 2022

Application Notes

Whole blood analysis using UV-Vis spectroscopy

12 Oct 2022

Application Notes

Choosing the best components for your diagnostic kit

6 Sept 2022

Resources

Resources Filter

Search

Selected Filters:

Explore the services BBI Solutions has to offer

Point-of-care monitoring for drugs of abuse

Oncology research: Monitoring disease from diagnosis to remission

The importance of human leukocyte antigen for the development of cell therapies

IBDoc® Calprotectin Home Test: A Step Forward towards Patient Empowerment

Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study

Complete solutions for lateral flow assay development

SARS-CoV-2 antibodies and antigens from Merck

News on diagnostics: Assay development and manufacture within the IVD market

Microsphere coupling: Two-step EDC/Sulfo NHS covalent coupling procedure for Estapor carboxyl-modified dyed microspheres

Larger spheres equate to higher sensitivity: New Estapor IT 250 microspheres for LTIA

Comparison of Estapor XC and Europium fluorescent microspheres in a quantitative lateral flow assay

Lateral flow assay development services

Webinars to earn CE credits as a medical technologist

N Latex FLC kappa and lambda assays

Implementation of N latex free light chain kappa and lambda assays into routine practice

Add consistency to monoclonal gammopathy testing: N latex FLC kappa and lambda assays

N latex FLC ratio for definition of ultra-high-risk smoldering multiple myeloma (SMM) - validation of the FLC rule 100

The role of rapid diagnostics in tackling antimicrobial resistance

Evaluation of the accuracy of LumiraDx INR Test in patients taking Phenprocoumon as VKA Therapy

Performance evaluation of a rapid multiplex point-of-care microfluidic immunofluorescence assay for the detection of SARS-CoV-2 Antigen and Flu A/B

Performance evaluation of a microfluidic point of care test for C-Reactive Protein

Correlation of the LumiraDx SARS-CoV-2 antibody Test to other SARS-CoV-2 antibody tests and to viral neutralization

Whole blood analysis using UV-Vis spectroscopy

Choosing the best components for your diagnostic kit

Resources

Resources FilterResources Filter

Search

Selected Filters:

Explore the services BBI Solutions has to offer

Point-of-care monitoring for drugs of abuse

Oncology research: Monitoring disease from diagnosis to remission

The importance of human leukocyte antigen for the development of cell therapies

IBDoc® Calprotectin Home Test: A Step Forward towards Patient Empowerment

Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study

Complete solutions for lateral flow assay development

SARS-CoV-2 antibodies and antigens from Merck

News on diagnostics: Assay development and manufacture within the IVD market

Microsphere coupling: Two-step EDC/Sulfo NHS covalent coupling procedure for Estapor carboxyl-modified dyed microspheres

Larger spheres equate to higher sensitivity: New Estapor IT 250 microspheres for LTIA

Comparison of Estapor XC and Europium fluorescent microspheres in a quantitative lateral flow assay

Lateral flow assay development services

Webinars to earn CE credits as a medical technologist

N Latex FLC kappa and lambda assays

Implementation of N latex free light chain kappa and lambda assays into routine practice

Add consistency to monoclonal gammopathy testing: N latex FLC kappa and lambda assays

N latex FLC ratio for definition of ultra-high-risk smoldering multiple myeloma (SMM) - validation of the FLC rule 100

The role of rapid diagnostics in tackling antimicrobial resistance

Evaluation of the accuracy of LumiraDx INR Test in patients taking Phenprocoumon as VKA Therapy

Performance evaluation of a rapid multiplex point-of-care microfluidic immunofluorescence assay for the detection of SARS-CoV-2 Antigen and Flu A/B

Performance evaluation of a microfluidic point of care test for C-Reactive Protein

Correlation of the LumiraDx SARS-CoV-2 antibody Test to other SARS-CoV-2 antibody tests and to viral neutralization

Whole blood analysis using UV-Vis spectroscopy

Choosing the best components for your diagnostic kit

Resources Filter